CLINICAL

Drug Maker Ordered to Shut DownAfter repeated infractions, a company is forced to shutter its doors.
Are Rebates Responsible for Higher Drug Costs?A new study shows how the Medicare donut hole could be costing patients.
Omnicell System Streamlines Medication ManagementNew technology is helping patients, nurses, and pharmacists alike.
Pharmacy Education: Foundation for Providing HealthAACP offers a rebuttal to Drug Topics opinion article.
Immunizations Across the Adult Lifespan
Immunizations Across the Adult LifespanVaccinations in adulthood play an important role in public health and in reducing the morbidity and mortality associated with infections.
Abuse-Deterrent Opioid Rexista Makes Misusers Blue—LiterallyHow one opioid abuse deterrent could make it easy to identify misuse.
Safinamide (Xadago): Approved as Add-On for Parkinson’sXadago has been approved as a supplementary medication for patients with Parkinson's disease who are having "off" episodes or whose disease is progressing.
Autoimmune Drug Market Could Take OffWhy the market is expecting such significant growth (and how pharmacists can keep their patients in the huge market).
BP Control in Cardiac Surgery: Nitroprusside AlternativesPharmacists must find good alternative therapeutic substitutions for sodium nitroprusside in the face of price gouging and drug shortages.
Development Soars for Alzheimer’s DrugsThere is lots of room for both success and failure in the Alzheimer's drug market.

Poll